Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03897543 · ClinicalTrials.gov registry record · Phase 1

ABX196 in Combination With Nivolumab in Patients With Hepatocellular Carcinoma

A Phase 1 study of Carcinoma, Hepatocellular, sponsored by Abivax S.A..

Recruiting
Registry status
Phase 1
Development phase
48
Enrollment target
2
Study locations

NCT03897543 is a Phase 1 study of Carcinoma, Hepatocellular that is actively recruiting participants, run by Abivax S.A.. The registered enrollment target is 48 participants, below the 611-participant average among 27 other Carcinoma, Hepatocellular trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03897543, a Phase 1 study of Carcinoma, Hepatocellular, is actively recruiting participants, sponsored by Abivax S.A..

RECRUITING
Registry status
Phase 1
Development phase
48 participants
Enrollment target
2
Study locations

Study Summary

Open-label, uncontrolled, phase 1-2 study to evaluate the safety, tolerability, pharmacodynamic effects, and preliminary efficacy of ABX196 administered in combination with nivolumab in patients with hepatocellular carcinoma

Conditions Studied

Carcinoma, Hepatocellular

Interventions

  • DRUG ABX196

Study Locations (2)

California

  • Scripps Clinic Torrey Pines - La Jolla

Texas

  • MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2019-08-30
Est. Completion 2023-06-30
Phase Phase 1

Sponsor

Abivax S.A.

6 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03897543

The ClinicalTrials.gov registry entry for NCT03897543 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 611-participant average among 27 other Carcinoma, Hepatocellular trials with a reported enrollment target (92% lower). The listed sponsor is Abivax S.A., which has 6 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Carcinoma, Hepatocellular appearing as the primary indexed condition, and to 1 intervention - of which ABX196 is the first listed.

NCT03897543 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Texas.

Frequently Asked Questions

What is clinical trial NCT03897543 about?

NCT03897543 is a clinical study titled "ABX196 in Combination With Nivolumab in Patients With Hepatocellular Carcinoma". Open-label, uncontrolled, phase 1-2 study to evaluate the safety, tolerability, pharmacodynamic effects, and preliminary efficacy of ABX196 administered in combination with nivolumab in patients with hepatocellular carcinoma

What is the current status of trial NCT03897543?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 48 participants. The study started on 2019-08-30. Estimated completion is 2023-06-30.

What conditions does trial NCT03897543 study?

This clinical trial studies the following conditions: Carcinoma, Hepatocellular.

What interventions are being tested in trial NCT03897543?

The interventions under investigation include: ABX196 (DRUG).

Who is sponsoring clinical trial NCT03897543?

This trial is sponsored by Abivax S.A., which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03897543 being conducted?

This trial has 2 study locations across California, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Carcinoma, Hepatocellular

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Carcinoma, Hepatocellular

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.